Buprenorphine shared medical appointments for the treatment of opioid dependence in a homeless clinic

References

• Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-Year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet. 2003;361:662–668.
   PubMed Web of Science ®Google Scholar
• National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280:1936–1943.
   PubMed Web of Science ®Google Scholar
• Fiellin DA, O'Connor PG. Clinical practice. Office-based treatment of opioid-dependent patients. N Engl J Med. 2002;347:817–823.
   PubMed Web of Science ®Google Scholar
• Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949–958.
   PubMed Web of Science ®Google Scholar
• Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005;20:1038–1041.
   PubMed Web of Science ®Google Scholar
• Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 1992;267:2750–2755.
   PubMed Web of Science ®Google Scholar
• Magura S, Lee SJ, Salsitz EA, et al. Outcomes of buprenorphine maintenance in office-based practice. J Addict Dis. 2007;26:13–23.
   PubMed Web of Science ®Google Scholar
• Ling W, Charuvastra C, Collins JF, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction. 1998;93:475–486.
   PubMed Web of Science ®Google Scholar
• Netherland J, Botsko M, Egan JE, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36:244–251. doi: 10.1016/j.jsat.2008.06.006.
   PubMed Web of Science ®Google Scholar
• Noffsinger EB. The ABC of Group Visits. London: Springer; 2012.
   Google Scholar
• Riley SB, Marshall ES. Group visits in diabetes care: a systematic review. Diabetes Educ. 2010;36:936–944. doi: 10.1177/0145721710385013.
   PubMed Web of Science ®Google Scholar
• Masley S, Phillips S, Copeland JR. Group office visits change dietary habits of patients with coronary artery disease-the dietary intervention and evaluation trial (D.I.E.T.). J Fam Pract. 2001;50:235–259.
   PubMed Web of Science ®Google Scholar
• Kawasaki L, Muntner P, Hyre AD, Hampton K, DeSalvo KN. Willingness to attend group visits for hypertension treatment. Am J Manag Care. 2007;13:257–262.
   PubMed Web of Science ®Google Scholar
• Shojania K, Ratzlaff M. Group visits for rheumatoid arthritis patients: a pilot study. Clin Rheumatol. 2010;29:625–628. doi: 10.1007/s10067-010-1379-5.
   PubMed Web of Science ®Google Scholar
• Breakey WR, Fischer PJ, Kramer M, et al. Health and mental health problems of homeless men and women in Baltimore. JAMA. 1989;262:1352–1357.
   PubMed Web of Science ®Google Scholar
• Wright JD. The health of homeless people: evidence from the National Health Care for the Homeless Program. In: Brickner PW, Scharer LK, Conanan B, et al., eds. Under the Safety Net: The Health and Social Welfare of the Homeless in the United States. New York: Norton; 1990:15–31.
   Google Scholar
• Hibbs JR, Benner L, Klugman L, et al. Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med. 1994;331:304–309.
   PubMed Web of Science ®Google Scholar
• Hwang SW, Orav EJ, O'Connell JJ, Lebow JM, Brennan TA. Causes of death in homeless adults in Boston. Ann Intern Med. 1997;126:625–628.
   PubMed Web of Science ®Google Scholar
• Barrow SM, Herman DB, Córdova P, Struening EL. Mortality among homeless shelter residents in New York City. Am J Public Health. 1999;89:529–534.
   PubMed Web of Science ®Google Scholar
• Cheung AM, Hwang SW. Risk of death among homeless women: a cohort study and review of the literature. CMAJ. 2004;170:1243–1247.
   PubMed Web of Science ®Google Scholar
• Baggett TP, Hwang SW, O'Connell JJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA. 2013;173:189–195.
   Google Scholar
• Baggett TP, Chang Y, Singer DE, et al. Tobacco-, alcohol-, and drug-attributable deaths and their contribution to mortality disparities in a cohort of homeless adults in Boston. Am J Public Health. 2015;105:1189–1197. doi: 10.2105/AJPH.2014.302248.
   PubMed Web of Science ®Google Scholar
• Fox AD, Chamberlain A, Sohler NL, Frost T, Cunningham CO. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants. J Subst Abuse Treat. 2015;48:112–116. doi: 10.1016/j.jsat.2014.07.015.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Zinser J, Klaiber B, et al. Feasibility of implementing shared medical appointments (SMAs) for office-based opioid treatment with buprenorphine: a pilot study. Subst Abus. 2015;36:166–169. doi: 10.1080/08897077.2014.998400.
   PubMed Web of Science ®Google Scholar
• Berger R, Pulido C, Lacro J, Groban S, Robinson S. Group medication management for buprenorphine/naloxone in opioid-dependent veterans. J Addict Med. 2014;8:415–420. doi: 10.1097/ADM.0000000000000071.
   PubMed Web of Science ®Google Scholar
• Song JY, Safaeian M, Strathdee SA, Vlahov D, Celentano DD. The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health. 2000;77:678–687.
   PubMed Web of Science ®Google Scholar
• Öhlin L, Hesse M, Fridell M, Tätting P. Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile. BMC Psychiatry. 2011;11:81. doi: 10.1186/1471-244X-11-81.
   PubMed Web of Science ®Google Scholar
• Kraybill K, Zerger S. Providing Treatment for Homeless People With Substance Use Disorders. Nashville, TN: National Health Care for the Homeless Council; 2003. http://www.nhchc.org/wp-content/uploads/2011/09/CA05RCaseStudies-FINAL5.pdf. Accessed June 13, 2016.
   Google Scholar
• Cunningham C, Giovanniello A, Sacajiu G, et al. Buprenorphine treatment in an urban community health center: what to expect. Fam Med. 2008;40:500–506.
   PubMed Web of Science ®Google Scholar
• Alford DP, LaBelle CT, Richardson JM, et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med. 2007;22:171–176.
   PubMed Web of Science ®Google Scholar
• Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Med. 2007;5:146–150.
   PubMed Web of Science ®Google Scholar
• Lee JD, Grossman E, DiRocco D, Gourevitch MN. Home buprenorphine/naloxone induction in primary care. J Gen Intern Med. 2009;24:226–232. doi: 10.1007/s11606-008-0866-8.
   PubMed Web of Science ®Google Scholar